445 MEK inhibition enhances gemcitabine efficacy by increasing MDM2-mediated ubiquitination and degradation of RRM1
| Autor: | Vena, F., Li Causi, E., Hagemann, T., Hartley, J.A., Goodstal, S., Hochhauser, D. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2014 50 Supplement 6:146-146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect